BelCARDIO® – RAPID TEST (IVD)

MYOCARDIAL INFARCTION PATIENT, ISN’T IT?

“Time is Heart!” – To effectively diagnose and to treat early on means saving lives, preventing long-term damage and suffering. Whether you are a medical practitioner, in an emergency room or on a rescue mission, you need to diagnose thoracic pain or similar symptoms of your patient quickly and without any doubt.

Whether a heart attack has occurred or another cause seems probable cannot always be determined with certainty. Even in the absence of ECG changes, e.g. the NSTEMI infarct, which can occur in up to 25%. The BelCARDIO® rapid test reliably detects whether your patient has suffered a myocardial infarction.

In daily use the rapid test permits the detection of whether a heart attack is present or not in patients with thoracic pain and cardiac origin. Even a mild myocardial infarction or an infarction without ECG changes can be detected.

Detect heart attack in minutes

DIAGNOSTICS IN DAILY PRACTICE

Already about one and a half hours after the myocardial infarction, irreversible cardiac damage usually occurs. The earlier the myocardial infarction can be diagnosed, the faster the patient can be sent to the cardiac catheter laboratory and the occluded vessel reopened and splinted by a stent.

The qualitative point-of-care test BelCARDIO uses two biomarkers, “hFABP” (Heart-type fatty acid binding protein), which is detectable in capillary blood about 20 minutes after the incident, and the biomarker “Troponin I”, which can be reliably detected only about 4 hours after an acute myocardial infarction.

Both biomarkers are capable of detecting myocardial infarction with high specificity and an accuracy of about 90% within a time frame of about 30 minutes to 8 days.

In a few minutes you will receive with double certainty all information for your diagnosis and thus increase the patient’s chances of recovery and thus reduce permanent damage to the patient.

ABSTRACT

For use by healthcare professionals only.

Already about one and a half hours after the myocardial infarction, irreversible cardiac damage usually occurs. The earlier the myocardial infarction can be diagnosed, the faster the patient can be sent to the cardiac catheter laboratory and the occluded vessel reopened and splinted by a stent.

In combination, BelCARDIO uses the fast biomarker hFABP and the proven long-term biomarker cTnI. Thus, 30 minutes after coronary artery thrombosis, a heart attack can be safely diagnosed or excluded on site without any other aids.

For use by healthcare professionals only.